Recent advancements in artificial intelligence (AI) and the vast data generated by modern clinical systems have driven the development of AI solutions in medical imaging, encompassing image reconstruction, segmentation, diagnosis, and treatment planning. Despite these successes and potential, many stakeholders worry about the risks and ethical implications of imaging AI, viewing it as complex, opaque, and challenging to understand, use, and trust in critical clinical applications. The FUTURE-AI guideline for trustworthy AI in healthcare was established based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability. Through international consensus, a set of recommendations was defined, covering the entire lifecycle of medical AI tools, from design, development, and validation to regulation, deployment, and monitoring. In this paper, we describe how these specific recommendations can be instantiated in the domain of medical imaging, providing an overview of current best practices along with guidelines and concrete metrics on how those recommendations could be met, offering a valuable resource to the international medical imaging community.

Despite technological and medical advances, the detection, interpretation, and treatment of cancer based on imaging data continue to pose significant challenges. These include inter-observer variability, class imbalance, dataset shifts, inter- and intra-tumour heterogeneity, malignancy determination, and treatment effect uncertainty. Given the recent advancements in image synthesis, Generative Adversarial Networks (GANs), and adversarial training, we assess the potential of these technologies to address a number of key challenges of cancer imaging. We categorise these challenges into (a) data scarcity and imbalance, (b) data access and privacy, (c) data annotation and segmentation, (d) cancer detection and diagnosis, and (e) tumour profiling, treatment planning and monitoring. Based on our analysis of 164 publications that apply adversarial training techniques in the context of cancer imaging, we highlight multiple underexplored solutions with research potential. We further contribute the Synthesis Study Trustworthiness Test (SynTRUST), a meta-analysis framework for assessing the validation rigour of medical image synthesis studies. SynTRUST is based on 26 concrete measures of thoroughness, reproducibility, usefulness, scalability, and tenability. Based on SynTRUST, we analyse 16 of the most promising cancer imaging challenge solutions and observe a high validation rigour in general, but also several desirable improvements. With this work, we strive to bridge the gap between the needs of the clinical cancer imaging community and the current and prospective research on data synthesis and adversarial networks in the artificial intelligence community.

Computer-aided detection systems based on deep learning have shown great potential in breast cancer detection. However, the lack of domain generalization of artificial neural networks is an important obstacle to their deployment in changing clinical environments. In this study, we explored the domain generalization of deep learning methods for mass detection in digital mammography and analyzed in-depth the sources of domain shift in a large-scale multi-center setting. To this end, we compared the performance of eight state-of-the-art detection methods, including Transformer based models, trained in a single domain and tested in five unseen domains. Moreover, a single-source mass detection training pipeline was designed to improve the domain generalization without requiring images from the new domain. The results show that our workflow generalized better than state-of-the-art transfer learning based approaches in four out of five domains while reducing the domain shift caused by the different acquisition protocols and scanner manufacturers. Subsequently, an extensive analysis was performed to identify the covariate shifts with the greatest effects on detection performance, such as those due to differences in patient age, breast density, mass size, and mass malignancy. Ultimately, this comprehensive study provides key insights and best practices for future research on domain generalization in deep learning based breast cancer detection.

The two-dimensional nature of mammography makes estimation of the overall breast density challenging, and estimation of the true patient-specific radiation dose impossible. Digital breast tomosynthesis (DBT), a pseudo-3D technique, is now commonly used in breast cancer screening and diagnostics. Still, the severely limited 3rd dimension information in DBT has not been used, until now, to estimate the true breast density or the patient-specific dose. This study proposes a reconstruction algorithm for DBT based on deep learning specifically optimized for these tasks. The algorithm, which we name DBToR, is based on unrolling a proximal-dual optimization method. The proximal operators are replaced with convolutional neural networks and prior knowledge is included in the model. This extends previous work on a deep learning-based reconstruction model by providing both the primal and the dual blocks with breast thickness information, which is available in DBT. Training and testing of the model were performed using virtual patient phantoms from two different sources. Reconstruction performance, and accuracy in estimation of breast density and radiation dose, were estimated, showing high accuracy (density <±3%; dose <±20%) without bias, significantly improving on the current state-of-the-art. This work also lays the groundwork for developing a deep learning-based reconstruction algorithm for the task of image interpretation by radiologists.

Breast magnetic resonance imaging (MRI) and X-ray mammography are two image modalities widely used for early detection and diagnosis of breast diseases in women. The combination of these modalities, traditionally done using intensity-based registration algorithms, leads to a more accurate diagnosis and treatment, due to the capability of co-localizing lesions and susceptibles areas between the two image modalities. In this work, we present the first attempt to register breast MRI and X-ray mammographic images using intensity gradients as the similarity measure. Specifically, a patient-specific biomechanical model of the breast, extracted from the MRI image, is used to mimic the mammographic acquisition. The intensity gradients of the glandular tissue are directly projected from the 3D MRI volume to the 2D mammographic space, and two different gradient-based metrics are tested to lead the registration, the normalized cross-correlation of the scalar gradient values and the gradient correlation of the vectoral gradients. We compare these two approaches to an intensity-based algorithm, where the MRI volume is transformed to a synthetic computed tomography (pseudo-CT) image using the partial volume effect obtained by the glandular tissue segmentation performed by means of an Expectation-Maximization algorithm. This allows us to obtain the digitally reconstructed radiographies by a direct intensity projection. The best results are obtained using the scalar gradient approach along with a transversal isotropic material model, obtaining a target registration error (TRE), in millimeters, of 5.65 ± 2.76 for CC- and of 7.83 ± 3.04 for MLO-mammograms, while the TRE is 7.33 ± 3.62 in the 3D MRI. We also evaluate the effect of the glandularity of the breast as well as the landmark position on the TRE, obtaining moderated correlation values (0.65 and 0.77 respectively), concluding that these aspects need to be considered to increase the accuracy in further approaches.

In this paper, we aim to produce a realistic 2-D projection of the breast parenchymal distribution from a 3-D breast magnetic resonance image (MRI). To evaluate the accuracy of our simulation, we compare our results with the local breast density (i.e., density map) obtained from the complementary full-field digital mammogram. To achieve this goal, we have developed a fully automatic framework, which registers MRI volumes to X-ray mammograms using a subject-specific biomechanical model of the breast. The optimization step modifies the position, orientation, and elastic parameters of the breast model to perform the alignment between the images. When the model reaches an optimal solution, the MRI glandular tissue is projected and compared with the one obtained from the corresponding mammograms. To reduce the loss of information during the ray-casting, we introduce a new approach that avoids resampling the MRI volume. In the results, we focus our efforts on evaluating the agreement of the distributions of glandular tissue, the degree of structural similarity, and the correlation between the real and synthetic density maps. Our approach obtained a high-structural agreement regardless the glandularity of the breast, whilst the similarity of the glandular tissue distributions and correlation between both images increase in denser breasts. Furthermore, the synthetic images show continuity with respect to large structures in the density maps.